Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the Netherlands
The aim of this study was to describe health-related quality of life (HRQoL) and productivity in Dutch breast cancer patients treated with tamoxifen in an adjuvant setting. Patients who started treatment with a standard dose of tamoxifen and who gave written informed consent, were eligible for participation in this trial. A total of 145 patients were asked to complete a survey at 3 months (T1) and 6 months (T2) after initiation of tamoxifen. HRQoL was measured by the EQ-5D-5L and the FACT-B questionnaire, and productivity by using the iMTA Productivity Costs Questionnaire. At 3 months 137 (95%... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2023 |
Reihe/Periodikum: | Kleijburg , A , Braal , C L , Westenberg , J D , Jager , A , Koolen , S L W , Mathijssen , R H J , Uyl-de Groot , C A , Wetzelaer , P & Penton , H 2023 , ' Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the Netherlands ' , Biomedicine and Pharmacotherapy , vol. 158 , 114158 . https://doi.org/10.1016/j.biopha.2022.114158 |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27623318 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://research.vumc.nl/en/publications/51952b9f-2cdf-4fc7-af25-5b919db8765a |